Transcriptomic analysis of Actinobacillus pleuropneumoniae S6 in response to SU3327
This study investigates the transcriptomic response of Actinobacillus pleuropneumoniae S6 to the novel antibacterial compound SU3327. The objective is to elucidate the compound's dual-target mechanism of action by analyzing changes in gene expression via RNA-Seq.